Discover how the new McDonald criteria use imaging biomarkers such as the Central Vein Sign (CVS) to make earlier, more accurate MS diagnosis
Learn how QMENTA simplifies central vein detection in Multiple Sclerosis. Our solution automates protocol adherence, sequence recognition, and white...
Discover how the Central Vein Sign (CVS) may enhance diagnostic accuracy, advance research outcomes, and influence the McDonald criteria.
Unleashing automated white matter lesion segmentation: Advancements in MS assessment. Evolving imaging techniques, revolutionizing diagnosis &...
For centuries, MS was recognized as a condition characterized by episodic and progressive neurological deterioration, classified as ‘paraplegia’
Companies and technicians that are developing new algorithms to help researches and professionals to diagnose and measure diseases progression...
QMENTA’s AI Platform Selected for the CAVS-MS Multiple Sclerosis Biomarker...
A new article detailing how COVID-19 effects people with MS,outlining potential risks and recommendations for people with Multiple sclerosis.
#ConquerCovid, a collaborative, time-sensitive initiative designed to help the global medical community fight the COVID-19 pandemic.